Successful Treatment of Rituximab-Refractory Waldenstrom Macroglobulinemia-Related Kidney Damage With Bruton Tyrosine Kinase Inhibitor
Kidney Int Rep
.
2021 May 5;6(7):1996-1997.
doi: 10.1016/j.ekir.2021.04.024.
eCollection 2021 Jul.
Authors
Guangyan Nie
1
,
Lianqin Sun
1
,
Bin Sun
1
,
Huayuan Zhu
2
,
Jianyong Li
2
,
Changying Xing
1
,
Bo Zhang
1
Affiliations
1
Department of Nephrology, The First Affiliated Hospital of Nanjing Medical University (Jiangsu Province Hospital), Nanjing, China.
2
Department of Hematology, The First Affiliated Hospital of Nanjing Medical University (Jiangsu Province Hospital), Nanjing, China.
PMID:
34307996
PMCID:
PMC8258498
DOI:
10.1016/j.ekir.2021.04.024
No abstract available